MVA-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine MVA-PCAQ

Preferred Label : MVA-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine MVA-PCAQ;

NCIt synonyms : MVA-PCAQ; Recombinant MVA PSA/PAP/STEAP1/5T4 Vaccine MVA-PCAQ;

NCIt definition : A cancer vaccine consisting of recombinant replication-deficient modified vaccinia Ankara (MVA) viral vector encoding genes for the prostate cancer-associated antigens prostate-specific antigen (PSA), prostatic acid phosphatase (PAP), six-transmembrane epithelial antigen of the prostate 1 (STEAP1), and 5T4 oncofetal antigen, with potential immunostimulatory and antineoplastic activities. Upon administration, MVA-PSA/PAP/STEAP1/5T4 prostate cancer vaccine MVA-PCAQ expresses PSA, PAP, STEAP1 and 5T4 peptides, which may elicit humoral and cellular immune responses against prostate cancer cells expressing these antigens.;

NCI Metathesaurus CUI : CL1906843;

Details

Origin ID

C199486;

concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_target
- Metalloreductase STEAP1 [NCIt concept]
- Prostate-Specific Antigen [NCIt concept]
- Prostatic Acid Phosphatase [NCIt concept]
- Trophoblast Glycoprotein [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients